Wnt5 also controls IDO1 activity in DC via β-catenin signaling while maintaining continuous expression in several cancer cell lines via an AhR-IL-6-STAT3 (Signal Transducer And Activator Of Transcription 3) signaling loop, according to new research [16, 17]. The gene discussed is IDO1; the disease is cancer.